Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
Relmada Therapeutics (Nasdaq: RLMD) plans to host a conference call and webcast on Thursday, August 6, 2026 at 4:30 PM ET to discuss its financial results for the second quarter ended June 30, 2026, along with recent business progress.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Relmada Therapeutics (Nasdaq: RLMD) plans to host a conference call and webcast on Thursday, August 6, 2026 at 4:30 PM ET to discuss its financial results for the second quarter ended June 30, 2026, along with recent business progress.
According to Relmada, U.S. participants can dial 1-800-717-1738, international participants can dial 1-646-307-1865, and a webcast will be accessible via the Investors section of the company’s website, where a replay will also be available.
Details
Market move: RLMD -12.08% in the Jul 16 session. 2Q26 earnings date notice
On Jul 16, the day this news came out, RLMD closed 12.08% below the previous close. Argus tracked a trough of -8.7% from its starting point during tracking. Our momentum scanner recorded 23 alerts for this stock that day.
Data tracked by StockTitan Argus for the Jul 16 session.
Key Figures
- Earnings call time
- August 6, 2026 at 4:30 PM ET
- Q2 2026 results conference call and webcast
- US dial-in
- 1-800-717-1738
- Participant dial-in number for earnings call
- International dial-in
- 1-646-307-1865
- International participant dial-in for earnings call
Previous Earnings date Reports
-
Set timing for Q1 2026 results call and webcast with updates.
-
Announced Q4 2025 results date and related conference call details.
-
Scheduled Q3 2025 results release and webcast with dial-in access.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CORAL GABLES, Fla., July 16, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced plans to host a conference call and webcast on Thursday, August 6, 2026 at 4:30 PM ET to discuss financial results for the second quarter ended June 30, 2026, and recent business progress.
Conference Call and Webcast Information:
- Date: Thursday, August 6, 2026 at 4:30 PM ET
- Participant Dial-in (US): 1-800-717-1738
- Participant Dial-in (International): 1-646-307-1865
- Webcast Access: Click Here
A replay of the webcast will be available in the Investors section of the Relmada website at https://www.relmada.com/investors/ir-calendar.
About Relmada Therapeutics, Inc.
Relmada Therapeutics is a clinical-stage biotechnology company focused on developing transformative therapies for oncology and central nervous system conditions. Its lead candidates, NDV-01 and sepranolone, are advancing through mid-stage clinical development with the potential to address significant unmet needs.
For more information, visit www.relmada.com
Investor Contact:
Brian Ritchie
LifeSci Advisors
britchie@lifesciadvisors.com
Media Inquiries:
Corporate Communications
media@relmada.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.